Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-30

Clinical Trial Update: Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan [NA]

View source ↗

Summary

A completed clinical trial evaluating whether bismuth subsalicylate influences antimicrobial use among adult diarrhea outpatients in Pakistan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bismuth subsalicylate (bismuth subsalicylate)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Diarrhea | NA | Status: COMPLETED